T cell lymphoma co-expressing CD20

Diagnostic Histopathology

Volumn 16, Issue 2, 2010, Pages 111-113

  Cumiskey, Joanna ^a,b,c,d,e   Noonan, Sinead ^a,b,c,d,e   Cummins, Robert ^a,b,c,d,e   Quinn, Fiona ^a,b,c,d,e   Fennelly, David ^a,b,c,d,e   O'Briain, D Seán ^a,b,c,d,e   Kay, Elaine W ^a,b,c,d,e  

^a BEAUMONT HOSPITAL   (Ireland)

^b Blackrock Clinic Ireland   (Ireland)

^c ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^d ST JAMES S HOSPITAL   (Ireland)

^e ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

CD20 co expression; immunohistochemistry; T cell lymphoma

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CELL MARKER; CYCLOPHOSPHAMIDE; DNA; ETOPOSIDE; PARAFFIN; PREDNISOLONE; RITUXIMAB; T LYMPHOCYTE RECEPTOR; VINCRISTINE;

AGED; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; GENE REARRANGEMENT; HELPER CELL; HUMAN; IMMUNOGLOBULIN GENE; IMMUNOHISTOCHEMISTRY; MALE; PERIPHERAL T CELL LYMPHOMA; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; T CELL LYMPHOMA;

EID: 76449094689     PISSN: 17562317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mpdhp.2009.12.005     Document Type: Article

References (13)

1. Rahemtullah A., Longtine J.A., Harris N.L., et al. CD20+ T-cell lymphoma: clinicopathologic analysis of 9 cases and a review of the literature. Am J Surg Pathol 32 (2008 Nov) 1593-1607
2. Pilozzi E., Pulford K., Jones M., et al. Co-expression of CD79a (JCB117) and CD3 by lymphoblastic lymphoma. J Pathol 186 (1998 Oct) 140-143
3. Quintanilla-Martinez L., Preffer F., Rubin D., Ferry J.A., and Harris N.L. CD20+ T-cell lymphoma. Neoplastic transformation of a normal T-cell subset. Am J Clin Pathol 102 (1994 Oct) 483-489
4. Magro C.M., Seilstad K.H., Porcu P., and Morrison C.D. Primary CD20+CD10+CD8+ T-cell lymphoma of the skin with IgH and TCR beta gene rearrangement. Am J Clin Pathol 126 (2006 Jul) 14-22
5. Blakolmer K., Vesely M., Kummer J.A., Jurecka W., Mannhalter C., and Chott A. Immunoreactivity of B-cell markers (CD79a, L26) in rare cases of extranodal cytotoxic peripheral T (NK/T-) cell lymphomas. Mod Pathol 13 (2000) 766-772
6. Yao Z., Teruya-Feldstein J., Raffeld M., Sorbara L., and Jaffe E.S. Peripheral T-cell lymphoma with aberrant expression of CD79a and CD20: a diagnostic pitfall. Mod Pathol 14 (2001) 105-110
7. Sen F., Kang S., Cangiarella J., Kamino H., and Hymes K. CD20 positive mycosis fungoides: a case report. J Cutan Pathol 35 (2008 Apr) 398-403
8. Tedder T.F., Klejman G., Schlossman S.F., and Saito H. Structure of the gene encoding the human B lymphocyte differentiation antigen CD20 (B1). J Immunol 142 (1989 Apr 1) 2560-2568
9. Aboulafia D., Gown A.M., and Kidd P. AIDS-associated B-cell non-Hodgkin's lymphoma masquerading as a cutaneous T-cell neoplasm: an aberrant immunophenotype requiring comprehensive analysis for lineage resolution. Am J Dermatopathol 19 (1997 Feb) 66-72
10. Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. World Health Organization classification of tumours. Pathology and genetics. Tumours of the haematopoietic and lymphoid tissues (2001), IARC Press, Lyon, France 106-7
11. Castelli C., Rivoltini L., Andreola G., Carrabba M., Renkvist N., and Parmiani G. T-cell recognition of melanoma-associated antigens. J Cell Physiol 182 (2000 Mar) 323-331
12. Carbone A., Gloghini A., Gaidano G., Dalla-Favera R., and Falini B. BCL-6 protein expression in human peripheral T-cell neoplasms is restricted to CD30+ anaplastic large-cell lymphomas. Blood 90 (1997 Sep 15) 2445-2450
13. Rodriguez Pinilla S.M., Roncador G., Rodriguez-Peralto J.L., et al. Primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers. Am J Surg Pathol 33 (2009 Jan) 81-90